CAL
JAZZ icon

Capital Advisors Ltd’s Jazz Pharmaceuticals JAZZ Stock Holding History

Capital Advisors Ltd’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
2
– – ﹤0.01% 1476
2026
Q1 		$0 Hold
2
– – ﹤0.01% 1486
2025
Q4 		$0 Hold
2
– – ﹤0.01% 1461
2025
Q3 		$0 Buy
+2
New +$240 ﹤0.01% 1462
2025
Q2 		– Sell
-97
Closed -$12K – 1488
2025
Q1 		$12K Sell
97
-2
-2% -$261 ﹤0.01% 728
2024
Q4 		$12K Buy
99
+96
+3,200% +$11.3K ﹤0.01% 742
2024
Q3 		$0 Sell
3
-3
-50% -$329 ﹤0.01% 1497
2024
Q2 		$1K Buy
+6
New +$660 ﹤0.01% 1217
2023
Q4 		– Sell
-17
Closed -$2K – 1387
2023
Q3 		$2K Buy
+17
New +$2.27K ﹤0.01% 1014
2023
Q2 		– Sell
-2
Closed – – 1420
2023
Q1 		$0 Sell
2
-10
-83% -$1.48K ﹤0.01% 1377
2022
Q4 		$2K Buy
12
+11
+1,100% +$1.61K ﹤0.01% 865
2022
Q3 		$0 Buy
+1
New +$152 ﹤0.01% 1361
2021
Q2 		– Sell
-27
Closed -$4K – 483
2021
Q1 		$4K Buy
+27
New +$4.44K ﹤0.01% 459

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Capital Advisors Ltd's JAZZ Position: Q2 2026 in Review

Capital Advisors Ltd held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Capital Advisors Ltd first reported a position in JAZZ in Q1 2021 and has held it in 13 quarters since. The position peaked at $12K in Q1 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Capital Advisors Ltd held 2 shares of Jazz Pharmaceuticals worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1476 holding.
  • Capital Advisors Ltd first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 13 quarters since.
  • Capital Advisors Ltd's Jazz Pharmaceuticals position peaked at $12K in Q1 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.